Evidence map›Paper›PMID 30830794›Full record

ArticleJCO clinical cancer informatics2019

Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer.

Paul Riviere, Christopher Tokeshi, Jiayi Hou, Vinit Nalawade, Reith Sarkar, Anthony J Paravati, Melody Schiaffino, Brent Rose, Ronghui Xu, James D Murphy

Abstract read
In one paragraph

Article in JCO clinical cancer informatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paul RiviereUniversity of California, San Diego, La Jolla, CA.
Christopher TokeshiUniversity of Hawaii, Honolulu, HI.
Jiayi HouUniversity of California, San Diego, La Jolla, CA.
Vinit NalawadeUniversity of California, San Diego, La Jolla, CA.
Reith SarkarUniversity of California, San Diego, La Jolla, CA.
Anthony J ParavatiUniversity of California, San Diego, La Jolla, CA.
Melody SchiaffinoInstitute for Behavioral and Community Health, San Diego State University, San Diego, CA.
Brent RoseUniversity of California, San Diego, La Jolla, CA.
Ronghui XuUniversity of California, San Diego, La Jolla, CA.
James D MurphyUniversity of California, San Diego, La Jolla, CA.

Funding

UC San Diego Clinical and Translational Research InstituteTL1TR001443 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2019
$3.4M
NCATS NIH HHS TL1 TR001443
6 · The paper itself

Abstract

purposeTreatment decisions about localized prostate cancer depend on accurate estimation of the patient's life expectancy. Current cancer and noncancer survival models use a limited number of predefined variables, which could restrict their predictive capability. We explored a technique to create more comprehensive survival prediction models using insurance claims data from a large administrative data set. These data contain substantial information about medical diagnoses and procedures, and thus may provide a broader reflection of each patient's health.

methodsWe identified 57,011 Medicare beneficiaries with localized prostate cancer diagnosed between 2004 and 2009. We constructed separate cancer survival and noncancer survival prediction models using a training data set and assessed performance on a test data set. Potential model inputs included clinical and demographic covariates, and 8,971 distinct insurance claim codes describing comorbid diseases, procedures, surgeries, and diagnostic tests. We used a least absolute shrinkage and selection operator technique to identify predictive variables in the final survival models. Each model's predictive capacity was compared with existing survival models with a metric of explained randomness (ρ

resultsOur noncancer survival model included 143 covariates and had improved survival prediction (ρ

conclusionSurvival prediction models using high-dimensional variable selection techniques applied to claims data show promise, particularly with noncancer survival prediction. After further validation, these analyses could inform clinical decisions for men with prostate cancer.

Indexed as

Insurance Claim ReportingMedicareCause of DeathComorbidityHumansMalePrognosisProstatic NeoplasmsSEER ProgramSurvival AnalysisUnited States

Identifiers

PMID30830794
PMCPMC6873997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.